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Abstract
Background: DNA-dependent protein kinase (DNA-PK) is a DNA repair enzyme and plays an important role in determining
the molecular fate of the rAAV genome. However, the effect this cellular enzyme on rAAV DNA replication remains elusive.
Methodology/Principal Findings: In the present study, we characterized the roles of DNA-PK on recombinant adeno-
associated virus DNA replication. Inhibition of DNA-PK by a DNA-PK inhibitor or siRNA targeting DNA-PKcs significantly
decreased replication of AAV in MO59K and 293 cells. Southern blot analysis showed that replicated rAAV DNA formed
head-to-head or tail-to-tail junctions. The head-to-tail junction was low or undetectable suggesting AAV-ITR self-priming is
the major mechanism for rAAV DNA replication. In an in vitro replication assay, anti-Ku80 antibody strongly inhibited rAAV
replication, while anti-Ku70 antibody moderately decreased rAAV replication. Similarly, when Ku heterodimer (Ku70/80) was
depleted, less replicated rAAV DNA were detected. Finally, we showed that AAV-ITRs directly interacted with Ku proteins.
Conclusion/Significance: Collectively, our results showed that that DNA-PK enhances rAAV replication through the
interaction of Ku proteins and AAV-ITRs.
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Introduction
DNA-PK is a nuclear serine/threonine protein kinase that
consists of a 460 kDa catalytic subunit (DNA-PKcs) and a
heterodimer (Ku70 and Ku80). DNA-PK plays important roles
in DNA repair and V(D)J recombination through nonhomologous
end joining (NHEJ). When DNA-PK encounters DNA lesions
such as DNA double strand break (DSB) damage by ionizing
radiation, Ku70/80 binds with high affinity to DNA ends
independent of their end sequence or structure [1,2,3]. The Ku
heterodimer recruits DNA-PKcs to form an active DNA-PK
holoenzyme. LigaseIV/XRCC4 interacts with DNA-PK on DNA
ends, which leads to NHEJ [4,5]. Several proteins including
Mre11/Rad50/Nbs1 and Artemis are involved in this process
[6,7]. Activity of DNA-PKcs may be regulated by autopho-
sphorylation of DNA-PKcs at seven putative phosphorylation sites
including Thr
2609 and Ser
2056 [8,9]. Cells or animals lacking
DNA-PK functions are deficient in a protective response to
ionizing radiation and various radiomimetic agents [10,11]. DNA-
PK is a potential target protein in many cancer therapeutics since
inhibitors of DNA-PK can selectively sensitize tumor cells to
ionizing radiation. Wortmannin, an inhibitor of PI 3-kinase,
inhibits DNA-dependent protein kinase and sensitizes cells to
ionizing radiation (IR) [12,13]. In addition, wortmannin directly
binds to the kinase domain of DNA-PKcs and inhibits the function
of DNA-PKcs noncompetitively [14]. DNA-PK is a sensor
molecule that determines the cellular fates by regulating cellular
proteins related with cell cycles, DNA repair, and apoptosis
[9,15,16,17]. Paradoxically, the Ku70/80 complex can also inhibit
nonhomologous end joining when it binds to the telomere
complex, shelterin [18].
Adeno-associated virus (AAV) is a nonpathogenic human
parvovirus that contains a linear single-stranded DNA (ssDNA)
genome [19]. The AAV genome encodes two large open reading
frames, rep and cap, that are flanked by 145 nucleotide inverted
terminal repeats (ITRs). AAV has an interesting biphasic life cycle,
either productive infection in the presence of a helper virus, e.g.,
adenovirus or herpes simplex virus (HSV), or latent infection in the
absence of a helper virus. The ITRs comprise the Rep binding
elements (RBE and RBE’) and the terminal resolution site (trs) and
form a T-shaped hairpin structure that serves as the primer for
minimal origin of AAV DNA replication and for the site specific
nicking of the AAV ITR at the trs that is required for repairing
covalently closed ITRs during AAV replication [20,21,22,23]. The
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replication and trs nicking [20,24,25,26,27] and regulate AAV
gene expression [28,29,30,31,32,33,34] and packaging [35,36].
Rep68 or Rep78 also play important roles for site-specific
integration of wild type AAV2 into human chromosome
19q13.3qter, named the AAVS1 locus [37,38,39]. AAV DNA
replication requires the ITR, cellular polymerases, and helper
virus-derived factors. The p5 promoter region that regulates rep
gene expression is also involved in a reduced Rep-dependent
replication and site-specific integration that occurs in the absence
of the ITR and relies on the RBE and cryptic trs in the p5
promoter [40].
In addition to the Rep proteins and ITRs, AAV DNA
replication requires cellular proteins and helper virus-derived
factors depending on the helper virus used. In the presence of Ad,
in vitro replication assays suggest that four cellular complexes are
essential for AAV DNA replication; these are polymerase d,
proliferating cell nucelar antigen (PCNA), replication factor C
(RFC), and minichromosome maintenance complex (MCM)
[25,41,42,43]. The Ad and cellular single stranded DNA binding
proteins (DBP and RPA) have also been shown to stimulate AAV
DNA replication in vitro [43,44] [41]. Rep has been shown to
interact with all of these cellular and viral proteins [44,45].
In contrast to Ad helper infections, relatively little is known
about cellular proteins involved in AAV replication during
coinfection with Herpes simplex virus (HSV). The herpes helicase
primase complex and single stranded DNA binding protein are
essential for promoting AAV DNA replication in vivo at a minimal
level [44,46,47]. However, expression of the HSV DBP and
helicase/primase provide only 10% of the normal DNA
replication seen with wild type herpes coinfection [47]. This
suggests that other herpes genes provide essential functions and
some of these have recently been identified, (ICP0, ICP4, ICP22)
[48]. The herpes DNA polymerase, which appears to provide
partial helper function under some conditions [46,48], has also
been shown to be completely dispensable for rAAV production
[49], suggesting that a cellular polymerase may be necessary in the
presence of Herpes coinfection.
We have previously reported that DNA-PK is involved in
determining the molecular fate of the rAAV genome in skeletal
muscle and in liver [50,51]. However, the effect of DNA-PK on
AAV replication remains elusive. Nash et al (44) have recently
shown that Ku70/80 complex, which forms a complex with DNA-
PK, as well as DNA-PK, both form a complex with Rep78 during
productive infections in the presence of adenovirus. They also
showed that the DNA-PK/Ku70/Ku80 complex stimulates AAV
DNA replication in vitro, although it does not appear to be
essential. In this report we examine the effect of DNA-PK/Ku70/
80 on AAV DNA replication in the presence of HSV and Ad. In
order to test the effect of DNA-PK on rAAV replication, we have
employed both in vivo and in vitro replication assays. We
demonstrated that inhibition of DNA-PK by wortmannin or
siRNA resulted in decrease of rAAV replication in MO59K and
293 cells in the presence of Herpes virus and in 293 cells in the
presence of Ad helper functions. We also confirmed that depletion
of Ku proteins lead to a reduction of AAV replication in an in vitro
assay using Ad infected extracts.
Results
DNA-PK inhibitor, wortmannin Inhibits rAAV replication
In order to test the effect of DNA-PK on rAAV replication, we
first employed wortmannin, an inhibitor of DNA-PK [14]. DNA-
PK positive (+/+) cell lines, MO59K and 293 cells were infected
with rAAV2-UF5 with or without recombinant herpes helper virus
(containing the AAV2 rep and cap genes) [52]. Cells were treated
with different concentrations of wortmannin and two days after
viral co-infection, episomal DNA (Hirt DNA) was isolated.
Replicated forms of rAAV-UF5 DNA including double-stranded
monomer (about 3.4 kb), double-stranded dimer (about 6.8 kb)
and high molecular weight concatamers (over 13 kb) were
analyzed by Southern blot analysis using
32P labeled vector
specific (CMV) probe. As shown in Figure 1, treatment of
wortmannin decreased the rAAV genome replication in dose-
dependent manner in both cell lines. No significant cytotoxicity
was observed when wortmannin concentration was below 20 mM
in MO59K cells, or below 5 mM in 293 cells. We noticed that the
conversion of single-stranded AAV genome to double-stranded
monomer or concatamers was more efficient in 293 cells than in
MO59K cells, probably due to E1 gene expression in 293 cells
[53,54,55].
Targeting DNA-PKcs mRNA inhibits rAAV replication
The results above indicated that DNA-PK may play a role in
enhancing rAAV replication. However, wortmannin inhibits not
only DNA-PK, but also other protein kinases, such as phospha-
tidylinositol 3-kinase (PI-3). In order to pinpoint the role of DNA-
PK, we employed synthetic siRNA to target DNA-PKcs mRNA.
Synthetic siRNA at 100 pmole significantly decreased mRNA
Figure 1. rAAV replication in MO59K cells and 293 cell treated
with wortmannin. Hirt DNA was purified two days after viral infection
and subjected to Southern blot analysis. All samples were triplicated
and hybridized with
32P labeled CMV probe. Replicated forms of rAAV
include double-stranded monomer (about 3.4 kb), or dimer (about
6.8 kb), and concatamers DNA (high molecular weight). Notice that
treatment of wortmannin reduced rAAV replication in a dose-
dependent manner in both MO59K cells (A) and in 293 cells (B).
doi:10.1371/journal.pone.0015073.g001
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control siRNA or Lipofectamine
TM 2000 reagent alone showed no
effect. These results demonstrated that siRNA was efficient for
inhibition of DNA-PKcs. As shown in Figure 3A and B, inhibition
of DNA-PKcs by siRNA resulted in a significant decrease of rAAV
replication as compared with control siRNA treatment. The
inhibitory effect of the siRNA on rAAV replication was dose
dependent (Figure 3C). Since the rAAV genome is linear and
single stranded DNA, the viral infection may affect DNA-PK
activity [56,57,58]. To avoid the unwanted effect from viral
transduction of rAAV and rHSV [59], we evaluated rAAV
replication using transfected double stranded vector and helper
plasmids. Twenty-four hours after siRNA transfection, 293 cells
were co-transfected with pDG, which supplies all of the Ad helper
genes, and pUF5. Two days after the transfection, Hirt DNA was
isolated and digested with DpnI to remove plasmid DNA. Results
from this study again showed that inhibition of DNA-PK
decreased rAAV replication (Figure 3D).
Molecular analysis of replicated rAAV DNA
We and others have previously shown that in latent infections,
rAAV DNA forms mainly head-to-tail (H-T) junctions and persists
as an episome in liver and muscle cells. Cellular enzymes, such as
DNA-PK play important roles in the junction formation and
persistence of AAV DNA [50,51] and would be expected to
produce circular rAAV genomes with head to tail junctions.
Although AAV is known to replicate by a hairpin priming
mechanism, a rolling circle mechanism has been proposed during
the establishment of latent infections [60,61]. Unlike the self-
priming model, which generates head-to-head (H-H) or tail-to-tail
(T-T) junctions, the rolling circle model generates head-to-tail (H-
T) junctions. In order to evaluate the structures of replicated rAAV
junction and the effect of DNA-PK on junction formation,
we digested Hirt DNA with unique restriction enzymes, XbaI
(1-cutter), SacI (2-cutter), and NotI (2-cutter) as shown in Figure 4A.
All of the possible fragments generated from these digests are listed
in Figure 4B. Southern blot analysis using two different probes
showed that all predicted fragments (H-H, T-T, free ends) were
detected, except H-T junctions (Figure 4C). The low or
undetectable levels of head to tail junctions suggested AAV-ITR
self-priming was still the primary mechanism for AAV DNA
replication. Inhibition of DNA-PK did not affect the type of AAV
junction formed during AAV replication.
In vitro AAV replication
In order to confirm the observation that inhibition of DNA-PK
decreased rAAV replication in cells, we employed a previously
developed in vitro replication assay to explore the role of DNA-PK
and Ku70/80 [25,43]. In this assay, the reaction contains purified
Rep 68, dsAAV DNA template with covalently closed ends and
nuclear extract (NE) from adenovirus-infected HeLa cells. Since
HeLa cells express high levels of DNA-PK, we tested the effect of
selective inhibition of each subunit of the DNA-PK complex by
adding anti-DNA-PKcs, anti-Ku70, or anti-Ku80 antibodies to
the HeLa NE before starting the AAV replication reaction. As
shown in Figure 5A, addition of anti-Ku80 antibody significantly
inhibited rAAV replication (70%, P,0.05), while anti-Ku70
antibody showed a moderate decrease of rAAV replication
(33%, P=0.074). However, we did not observe inhibition of
AAV replication using anti-DNA-PKcs antibodies (Ab-23198–4127
or Ab-4cocktail). In order to rule out a non-specific effect of the
antibodies on AAV replication, we performed the assay with HeLa
nuclear extracts that had been depleted for DNA-PKcs or Ku
heterodimer. Specific depletion of DNA-PKcs by anti-DNA-PKcs
Ab-4Cocktail and Ku proteins by anti-Ku70/80 (Ku-Ab3) was
observed by Western blotting (Figure 5C). As shown in Figure 5D
and 5E, depletion of Ku70/80 decreased AAV replication
(P,0.05 by one-tailed distribution), while depletion of DNA-PK-
cs did not. The results from these in vitro replication studies
confirmed the previous report that Ku70/80 interacts with AAV
Rep protein in vivo, and that they can enhance in vitro AAV DNA
replication and partially substitute for MCM complex [45].
AAV-ITRs interact with Ku proteins
In order to test for a direct interaction between the AAV ITR
and DNA-PK, we built an AAV-ITR by annealing and ligating
three synthetic oligonuceotides. This ITR was then linked to a
magnetic particle (Figure 6A), and as expected, the ITR interacted
with Rep 78 (Figure 6B, right panel). In addition, using the ITR
coated magnetic particles, we successfully pulled down and
isolated Ku70 and Ku80 proteins (Figure 6B, left panel). To
eliminate the possibility that incomplete ITRs or single stranded
DNA interacted with the Ku proteins, we treated the ITR coated
beads with exonuclease III to remove any partially assembled
ITRs. As shown in Figure 6C, exonuclease III treatment did not
affect the interaction between the AAV-ITR and Ku proteins. The
interaction was also found to be a function of the concentration of
Ku proteins. Finally, when free competitor AAV-ITR was added
to the reaction, less Ku protein was pulled down (Figure 6D right)
although the streptavidin-coated beads alone weekly interact with
Ku 70 (Figure 6D left). These results demonstrated that Ku
proteins can directly bind to hairpined AAV-ITRs, even in the
absence of Rep protein.
Figure 2. Targeting DNA-PKcs by siRNA. 293 cells are transfected
with siRNA (100 pmole) targeting DNA-PKcs mRNA and non-specifically
control siRNA using Lipofectamine
TM 2000. Two days after transfection,
cells were harvested. (A) RT-PCR for the detection of DNA-PKcs mRNA.
Amplified cDNA fragments were separated on a 1% agarose gel. (B)
Western blot for the detection of DNA-PKcs protein using beta-actin
protein as an internal control.
doi:10.1371/journal.pone.0015073.g002
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AAV replication has been intensively investigated and the
contributions of AAV ITR sequences and Rep proteins have been
reasonably well defined [20,21,22,23,25,62,63,64,65,66,67,68].
However, the effects of cellular proteins on AAV replication are
not completely understood. Although the minimum set of proteins
required to replicate AAV DNA efficiently in vitro has been
identified for both Herpes and Ad infected cells
[41,42,43,44,46,47,49,69,70,71], it has recently been reported
that Rep protein interacts with 188 cellular proteins [45]. Some of
these Rep-interacting cellular factors play important roles in
cellular DNA replication or repair and are likely to have a role in
AAV DNA replication as well. Understanding these mechanism(s)
will enable us to enhance rAAV vector production and to develop
a safe gene delivery system. In the present study, we focused on the
role of the DNA-PK complex (DNA-PKcs and Ku70/80) in AAV
DNA replication.
Our results showed that reduction of DNA-PK at the protein or
RNA levels decreased rAAV replication, suggesting that one or
more components of the DNA-PK complex can enhance AAV
replication. In vivo, long-term inhibition of DNA-PKcs by
wortmannin and siRNA reduced rAAV replication in both
MO59K and 293 cells (Figs. 1, 2 and 3), indicating that DNA-
PKcs plays an important role in rAAV replication. Furthermore,
DNA-PKcs siRNA reduced AAV DNA replication when either
Herpes virus or Ad helper functions were used (Fig. 3). However,
when cell-free extracts were used in an in vitro replication assay,
depletion of DNA-PKcs did not affect rAAV replication suggesting
that the effect of DNA-PKcs observed in vivo was indirectly
through acting on downstream factors, such as Ku proteins.
Indeed, our results showed that Ku70 and Ku80, had a clear effect
in vitro when they were depleted by either antibody precipitation
or antibody addition (Fig. 5). Finally, we showed that the
components of the DNA-PK complex, particularly Ku70/80,
could bind to a hairpinned AAV ITR. Because the magnetically
tagged substrate used in these binding studies had a DNA end that
was blocked with a magnetic bead, our results showed the direct
interaction between Ku proteins and close-ended AAT-ITR.
These results are consistent with observations reported previously
using a ChIP assay [72]. Our results also are consistent with the
recent report by Nash et al [45], who showed that purified Ku70/
80 could partially substitute for the MCM helicase complex in an
AAV DNA replication assay. This group also showed by antibody
Figure 3. Targeting DNA-PKcs reduced rAAV replication. 293 cells were transfected with DNA-PKcs specific siRNA (DNA-PKcs siRNA) or control
siRNA. Two days after transfection, cells were infected with rAAV-UF5 and rHSV, or transfected with pUF5 and pDG. rAAV replication was evaluated by
Southern blot analysis as described in Figure 1. (A) Effect of DNA-PKcs siRNA on rAAV replication by Southern blot after vector infection.
Concentration of DNA-PKcs siRNA and control siRNA was 100 pmole. (B) Densitometry analysis of data from Figure A. **, P,0.001 for monomer; *,
P,0.05 for dimer and concatamers when compared with control siRNA group. (C) Dose dependent effect of DNA-PKcs siRNA on rAAV DNA
replication. (D) Effect of DNA-PKcs siRNA on rAAV after vector and helper plasmid transfection. Left panel, without DpnI digestion; Right panel after.
Note: DpnI digestion removes transfected plasmid DNA and shows all de novo replicated rAAV forms (monomer, dimer and concatamers).
doi:10.1371/journal.pone.0015073.g003
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68 in vivo that was independent of the presence of DNA. Together,
these results suggest that the enhancing effect of DNA-PKcs that
we observed in vivo was probably through phosphorylation of Ku
proteins, and suggested that Ku protein activated by DNA-Pkcs
stimulated AAV replication in vitro in the absence of DNA-PKcs.
DNA-PK is a DNA repair enzyme consisting of a large catalytic
subunit (DNA-PKcs), which has ser/thr kinase, and a heterodi-
meric complex consisting of Ku70 and Ku80 [73]. The Ku
heterodimer associates tightly with double stranded DNA breaks
and recruits DNA-PKcs, XRCC4 and Ligase IV to repair the
DNA break by non-homologous end joining [74,75,76]. Ku also
binds to telomeres via a high affinity interaction with TRF1, a
component of the telomere shelterin complex and has a role in
maintaining the stability of telomeres [18]. In contrast to its role in
DNA repair, when Ku binds telomeres, it prevents telomere end
joining. Finally, Ku has also been shown to have a 39 to 59 helicase
activity and ATPase activity [77] and these activities appear to be
unrelated to its binding of DNA ends.
We and others have shown that DNA-PK plays an important
role in processing recombinant AAV genomes [51,72,78,
79,80,81]. Injection of rAAV into scid mice (DNA-PKcs negative)
showed a persistence of linear episomal rAAV DNA containing
free ends in mouse tissue, in contrast to normal mice, in which all
of the free ends had been joined predominantly in a head to tail
fashion [78,79]. This result was consistent with the primary role of
the DNA-PK complex in NHEJ, and suggested that this
mechanism promoted rAAV DNA circulization, a key step in
establishing stable transduction. Curiously, Zentilin et al [72]
showed that in short term cell culture experiments (48 hrs),
transduction was increased in Ku80 negative cell lines in the
presence of hydroxyurea, suggesting that alternative mechanisms
for forming transducing genomes can exist in the absence of DNA
synthesis. In contrast, the results reported here showed that AAV
DNA synthesis in the presence of helper virus functions did not
result in circular intermediates or head to tail junctions, regardless
of whether Ku70/86 was activated by DNA-PKcs (Fig 5). This
suggests that the primary role of Ku70/80 in stimulating AAV
DNA replication is unrelated to its role in promoting NHEJ or
transduction. Our results are consistent with the recent report that
AAV replication in the presence of Ad coinfection stimulated a
DNA damage response that was primarily due to DNA-PKcs [58].
Given its inhibition of telomere end joining and its DNA
helicase activity, we can suggest two general mechanisms by which
Ku70/80 might stimulate AAV DNA synthesis. First, the
interaction with Rep and the ITR may prevent NHEJ of AAV
DNA replicative intermediates. This would be consistent with the
finding that the protein complex containing the Ad E4 orf 6 and
E1b 55K proteins targets the Mre11/Rad50/Nbs1 complex
(MRN) for degradation [82]. In the absence of these two Ad
helper functions for AAV (E1b55K and E4orf6), Ad DNA forms
concatemers, thereby inhibiting Ad DNA replication. The MRN
complex also localizes to AAV replication centers in the presence
of Ad coinfection and inhibits AAV DNA replication in the
absence of the E4orf6/E1b complex [83]. Therefore, the helper
function provided by E1b and E4orf6 is believed in part to be the
inhibition of MRN mediated NHEJ during AAV DNA replication.
By binding to AAV ITRs, Ku70/80 may also prevent interaction
of the ITR with MRN. Furthermore, by binding to the Rep-ITR
complex, Ku itself may be prevented from recruiting the other
Figure 4. Structure analysis of replicated DNA. (A) Map of the rAAV-UF5 vector; X (XbaI), S (SacI), and N (NotI), Two bold lines indicate the
position of CMV and Neo
R probes. (B) All possible genome sizes generated from different AAV junctions. I. F., internal fragment; H-H, head-to-head; T-
T, tail-to-tail; H-T, head-to-tail. (C and D) Southern hybridization probed with CMV (C), and Neo
R (D) after restriction enzyme digestion of Hirt DNA.
doi:10.1371/journal.pone.0015073.g004
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to the ITR and Rep would inhibit the two major NHEJ pathways
in mammalian cells.
Ku70/80 may also play a role in strand displacement synthesis.
We have shown previously that AAV DNA replication can be
reconstituted in vitro with purified proteins, including Rep, pol d,
PCNA and RFC [41,42]. Here and elsewhere, we have also shown
that replication can be at least partially reconstituted by
substituting Ku for MCM [45]. Both proteins have similar 39
DNA helicase activities that prefer a replication fork as a substrate
[77,84]; thus, both could function in AAV DNA replication as
strand displacement helicases. Neither has activity on blunt ended
DNA molecules [77,84] and, therefore, the initial melting of AAV
ends may be the function of Rep, which can bind to a Rep binding
element within the ITR and unwind the end [85]. Once a nascent
fork is established, either Ku or MCM can load onto the 39 strand
and unwind the rest of the ITR to form the hairpin primer
required for loading DNA polymerase and executing strand
displacement synthesis.
In summary, we have presented evidence both in vivo and in vitro
that the DNA-PK complex and in particular Ku70/80 stimulates
AAV DNA replication in the presence of both Ad and Herpes
coinfection. We have also suggested two possible mechanisms that
might account for this activity and guide future experiments.
Materials and Methods
Cells and Reagents
A human glioma cell line (MO59K) was obtained from ATCC
and was cultured in DMEM/F-12 medium (Cellgrow).Human
embryonic kidney 293 cells (Microbix) were cultured in Dulbecco’s
Minimal Essential Medium (DMEM). All media were supple-
mented with 10% fetal bovine serum (Cellgro), penicillin (100 U/
ml) and streptomycin (100 mg/ml). Wortmannin (Sigma) was
dissolved in DMSO at 10 mM and stored at 280uC.
rAAV transduction
The rAAV2-UF5 vector was produced at the University of
Florida Gene Therapy Center as described previously [86]. This
vector contains green fluorescent protein (GFP) cDNA driven by
cytomegalovirus (CMV) promoter. The titer of the rAAV-UF5
used in this study was 2.5610
13 physical particles/ml (1610
12
infectious unit/ml). To test AAV replication from viral DNA, cells
were infected with rAAV2-UF5 at 1000 particles/cell or co-
infected without recombinant HSV helper vector which contains
AAV rep and cap genes [52]. To test AAV replication from plasmid
DNA, cells were transfected 1.2 mg of helper plasmid (pDG), and
0.8 mg of pTR-UF5 by using Lipofectamine 2000
TM (Invitrogen).
Hirt DNA was purified two days after viral infection and was used
Figure 5. In vitro AAV replication. (A) In vitro AAV replication using nuclear extract (NE) supplemented with anti-DNA-PKcs Ab-23198–4127 (2, *),
anti-DNA-PKcs Ab-4cocktail (3, **), anti-Ku80 (4), anti-Ku70 (5), or with all antibodies (6). (B) Densitometry analysis of result from Figure 5A. Supplement
of anti-ku80 decreased AAV replication by 30% (DpnI-resistant AAV DNA, P,0.05 compared to sham control). (C) Western analysis shows the
depletion of DNA-PKcs, and Ku70/80. (D) In vitro AAV replication using DNA-PKcs (D-DNA-PKcs) or Ku70/80 (D-Ku80/70) depleted NE. Relative density
of each treatment (n=3) is plotted. * P,0.05.
doi:10.1371/journal.pone.0015073.g005
DNA-PK and AAV Replication
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genome. The densitometic quantification of AAV genomes was
performed with Kodak Gel Image Software.
siRNA transfection
Two double stranded RNA molecules were purchased from
Ambion (Austin, TX). The siRNA for DNA-PKcs (59-GAU CGC
ACC UUA CUC UGU U-39) targets the sequences of 352 base
and downstream sequences of human DNA-PKcs mRNA [87].
Silencer
TM Negative Control #2 siRNA from Ambion which does
not induce nonspecific effects on gene expression was used as a
transfection control. 293 cells at the number of 2.5610
5 cells/well
were cultured in 6-well plates and transfected with 100 pmole of
siRNA using Lipofectamine
TM 2000 (Invitrogen). Next day,
siRNA transfected cells were infected or transfected to test AAV
replication as described above.
RT-PCR
Total RNA was extracted from siRNA treated cells using
Trizol
TM reagent (Invitrogen) and RT-PCR was performed with
Access
TM RT-PCR kit (Promega) using 1 mg total RNA. Primers
were derived from the coding region of DNA-PK cDNA (upstream
primer: 59-ACT GAC ACA GAC TGC AGA TGG AAG-39,
downstream primer: 59-AGG GTG GAA AGA AAG AGA AGG
TGG-39). Beta-actin was used as a control (upstream primer: 59-
TCA CCA TGG ATG ATG ATA TCG CCG-39, downstream
primer: 59-ACA TGA TCT GGG TCA TCT TCT CGC).
Synthesis of the first strand cDNA was performed at 48uC for
45 min. The PCR were performed at 96uC for 1 min, 56uC for
1 min and 72uC for 2 min for 35 cycles. The amplified PCR
products were fractionated on a 1% agarose gel.
Western blot analysis
For western blot analysis, cell pellets were lysed in M-PER
TM
mammalian protein extraction reagent (Pierce) supplemented with
protease inhibitors (leupeptin, pepstatin, aprotinin, antipain, 1 mg/
ml each) and PMSF (at 1 mM). The protein concentration was
determined using BCA kit (Pierce). Thirty micrograms of total
cellular proteins were separated on 8% SDS-polyacrylamide gel
and transferred onto a nitrocellulose membrane (Amersham). The
mouse anti-DNA-PKcs (DNA- PKcs Ab-41–4127) or mouse anti-
Ku80 (Ku Ab-2610–705) or mouse anti-Ku70 (Ku Ab-4506–541) (all
antibodies were purchased from NeoMarkers) was used to detect
DNA-PKcs, or Ku80 or Ku70 respectively. Horseradish peroxi-
Figure 6. AAT-ITR interacts with Ku proteins. (A) construction of AAV-ITR on a magnetic particle. (B) ITR on magnetic bead interacts with Rep78
and Ku proteins. AAV-ITR was bound to purified proteins or HeLa nuclear extract (NE) at room temperature or 37uC and then subjected to western
blot analysis using antibodies toDNA-PKcs, Ku80 and Ku70. Rep78 are used as a positive control. (C) T-shaped closed ITR interact with Ku proteins in
dose-dependent manner. AAV-ITRs on the bead were treated with Exonuclease III and incubated with different amount of HeLa NE (65mg/ml). The ITR
binding proteins were subjected to western blot analysis for DNA-PKcs, Ku80 and Ku70. (D) Competition assay (right panel). When AAV-ITR on bead
was incubated with HeLa nuclear extract, free AAV-ITR was added (2.5 fold) as a competitor. Streptavidin-coated magnetic beads and the beads with
AAT-ITR (left panel) served as a control and showed addition of AAV-ITR increased pull down of Ku proteins.
doi:10.1371/journal.pone.0015073.g006
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was detected using ECL (Amersham).
In vitro AAV replication assay
In order to inhibit DNA-PK subunits, 25 mg( 1 ml) of Ad-
infected HeLa cell nuclear extract was preincubated with 1 mlo f
specific antibodies against each subunits of DNA-PK (each
200 mg/ml) for 30 min at 37uC. The AAV DNA replication assay
was performed as described previously [25]. Briefly, preincubated
Ad-infected HeLa cell extract with antibodies was incubated in a
reaction buffer containing 30 mM HEPES (pH 7.5), 7 mM
MgCl2, 0.5 mM DTT, 100 mM each dNTP, 25 mCi of [a-
32P]
dATP, 4 mM ATP, 40 mM creatine phosphate, 1 mg of creatine
phosphokinase, 0.1 mg of NE substrate DNA, and 1 to 80 U of
Rep68 baculovirus extract for 4 h at 37uC. After incubation, the
reaction mixture was treated with Proteinase K and extracted with
phenol/chloroform. DNA was precipitated in ethanol. The DNA
was digested with DpnI to remove bacterial DNA and was
separated by 0.8% agarose gel. X-ray film was exposed on a dried
gel.
Immunodepletions
In order to deplete DNA-PK subunits, 25 mg of Ad-infected
HeLa cell extract was mixed with 30 ml of anti-DNA-PKcs (DNA-
PKcs Ab-4cocktail), anti-Ku70/80 (Ku Ab-3) or control antibody
(mouse IgG2a Ab-1, Neomarkers) and incubated at 4uC overnight.
Each reaction was added with 50 ml of ProteinG-agarose
(Calbiochem) and incubated at 4uC overnight. DNA-PK subunits
interacted with the agarose beads were pelleted by centrifugation.
Supernatants were harvested carefully. This procedure was
repeated three times. The supernatant was used for in vitro
AAV replication studies as described above after confirm the
DNA-PK depletion by Western blot analysis.
Construction of synthetic AAV-ITR
A T-shaped AAV ITR was built by annealing and ligating
three synthetic oligos, ITR 1 (65-mer): 59-pGCTCGCTCACT-
GAGGCCGCCCGGGCAAAGCCCGGGCGTCGGGCGAC-
CTTTGGTCGCCCGGCCTCA-39, ITR 2 (35-mer): 59-pG-
TGAGCGAGCGAGCGCGCAGAGAGGGAGTGGCCAA-39,
ITR 3 (19-mer): 59-pTTGGCCACTCCCTCTCTGCGCGCTC-
39 (Figure 6A). This ITR was ligated with biotinated oligonucle-
otides, which can bind to streptavidin coated magnetic particles
(Roche Inc).
Assay for interaction between DNA-PK and AAV ITR DNA
AAV ITR on magnetic bead was incubated with purified DNA-
PK (containing DNA-PKcs, Ku80 and Ku70), HeLa nuclear
extract or Rep78 at room temperature or 37uC. The incubation
was performed in one of two buffers overnight containing either
25 mM HEPES (pH7.5), 5 mM MgCL2, 1 mM DTT and 1%
BSA or 20 mM HEPES (pH7.6), 1 mM EDTA, 10mM NH4SO4,
1mM DTT, 0.2% Tween 20 and 30 mM KCL. After incubation,
the magnetic beads were held by a magnet and washed 3 times
with the binding buffer. AAV-ITR binding proteins were eluted
out, dialyzed overnight following the instruction of the kit, and
subjected to western blot analysis.
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